Prevalence of rifampicin resistant pulmonary tuberculosis using geneXpert assay in Ethiopia, a systematic review and meta-analysis

M Demelash, E Nibret, T Hailegebriel, Z Minichil… - Heliyon, 2023 - cell.com
Background Drug-resistant tuberculosis continues to be a global public health threat.
Ethiopia is one of the high-burden countries for tuberculosis and multi-drug resistant …

Does Xpert® MTB/RIF assay give rifampicin resistance results without identified mutation? Review of cases from Addis Ababa, Ethiopia

A Alemu, M Tadesse, G Seid, H Mollalign… - BMC Infectious …, 2020 - Springer
Abstract Background Xpert® MTB/RIF assay is currently used in Ethiopia for the rapid
diagnosis of Mycobacterium tuberculosis (MTB) and mutations that confer Rifampicin …

High proportion of RR-TB and mutations conferring RR outside of the RRDR of the rpoB gene detected in GeneXpert MTB/RIF assay positive pulmonary tuberculosis …

GT Akalu, B Tessema, B Petros - PLoS One, 2022 - journals.plos.org
Background Globally, TB is the leading cause of infectious disease morbidity and mortality
with many diagnostic uncertainties. Access to affordable and rapid diagnostics remained a …

Trend of pulmonary tuberculosis and rifampicin-resistance among tuberculosis presumptive patients in Central Tigray, Ethiopia; 2018-2023: a six-year retrospective …

G Gebremariam, M Kiros, S Hagos, H Hadush… - … , Travel Medicine and …, 2024 - Springer
Background Tuberculosis (TB) is a major public health concern in the develo** countries.
Moreover, the emergence of multidrug-resistant tuberculosis is challenging. However, there …

Detection of Mycobacterium tuberculosis and rifampicin resistance by Xpert® MTB/RIF assay among presumptive tuberculosis cases at Jimma University Medical …

W Admassu, B Ayelign, G Abebe, M Tadesse - PLoS One, 2022 - journals.plos.org
Background Rapid diagnosis of tuberculosis (TB) and detection of drug resistance are very
important for timely and appropriate management of patients. Xpert MTB/RIF assay is …

[HTML][HTML] Xpert MTB/RIF assay for the diagnosis of Mycobacterium tuberculosis and Rifampicin resistance in high human immunodeficiency virus setting in gambella …

E Ejeta, G Beyene, Z Bonsa, G Abebe - Journal of clinical tuberculosis and …, 2018 - Elsevier
Background The introduction of a new and rapid molecular diagnostic for tuberculosis (TB)
and rifampicin resistance (RIF) in the national TB program has improved the diagnosis of TB …

Monitoring quality indicators for the Xpert MTB/RIF molecular assay in Ethiopia

A Kebede, D Beyene, B Yenew, G Diriba, Z Mehamd… - PLoS …, 2019 - journals.plos.org
Introduction In Ethiopia,> 300 GeneXpert instruments have been deployed for tuberculosis
(TB) testing using the Xpert MTB/RIF cartridge. Implementing quality indicators is necessary …

Magnitude of Mycobacterium tuberculosis Infection and Its Resistance to Rifampicin Using Xpert-MTB/RIF Assay Among Presumptive Tuberculosis Patients at Motta …

TA Demissie, D Belayneh - Infection and Drug Resistance, 2021 - Taylor & Francis
Background Mycobacterium Tuberculosis (MTB) and its drug resistance form are the
devastating infectious diseases in the world. It is the major cause of morbidity and mortality …

Trends of Mycobacterium tuberculosis and rifampicin resistance in Adigrat General Hospital, Eastern zone of Tigrai, North Ethiopia

GK Abay, BH Abraha - Tropical Diseases, Travel Medicine and Vaccines, 2020 - Springer
Background Tuberculosis is an infectious disease usually caused by Mycobacterium
tuberculosis bacteria. The global emergence of mono-or multidrug-resistant tuberculosis …

[HTML][HTML] Detection of Mycobacterium tuberculosis and rifampicin resistance by Xpert® MTB/RIF assay among presumptive tuberculosis patients in Addis Ababa …

G Diriba, A Alemu, HH Tola, K Eshetu, B Yenew… - IJID regions, 2022 - Elsevier
Objective This study aimed to determine the frequencies and trends of Mycobacterium
tuberculosis and rifampicin resistance among presumptive tuberculosis patients in Ethiopia …